Europe Archives

News and Trends 18 Sep 2023

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years.…

September 18, 2023 - 5 minutesmins - By Roohi Mariam Peter

Best in Biotech 29 Aug 2023

Are these 10 biotech recruiters on your radar this year?

The process of hunting for recruits can be a struggle for many companies, particularly when they have an ideal candidate in mind. And many at times, for the life science/biotech…

August 29, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 10 Feb 2023

Europe approves childhood epilepsy treatment

UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the European Union (EU) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) as an add-on therapy to other anti-epileptic…

February 10, 2023 - 3 minutesmins - By Jim Cornall

In Depth 6 Feb 2023

The biggest private biotech investments in January 2023

The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted…

February 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 12 Jan 2023

JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for multinational research on large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases.…

January 12, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 3 Jan 2023

Janssen looks for talquetamab marketing approval

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for approval of talquetamab for the treatment of patients…

January 3, 2023 - 2 minutesmins - By Jim Cornall

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU approval of Atara Biotherapeutics' Ebvallo marks the first immunotherapy based on T cells sourced from…

December 20, 2022 - 6 minutesmins - By Jonathan Smith

In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs) such as cell and gene therapies. However, changes are needed to ATMP regulations to keep…

December 15, 2022 - 8 minutesmins - By Jonathan Smith

News and Trends 7 Dec 2022

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the establishment of Neuraxpharm Netherlands, increasing its presences from two to 20…

December 7, 2022 - 3 minutesmins - By Liza Laws

News and Trends 6 Dec 2022

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help accelerate pipeline product development projects. The company will also use the funding for market development…

December 6, 2022 - 3 minutesmins - By Liza Laws

News and Trends 29 Nov 2022

Mycotechnology and IFF join forces in Europe to create better food system

Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership to co-develop alternative proteins. The two companies have already partnered in the U.S. and the…

November 29, 2022 - 2 minutesmins - By Liza Laws

News and Trends 17 Nov 2022

New EU project looks to unlock the potential of genomics

The European Genomic Data Infrastructure (GDI) project kicked off today in Brussels, Belgium. The new €40 million ($41.4 million) GDI project, coordinated by ELIXIR, is jointly funded by the European…

November 17, 2022 - 3 minutesmins - By Jim Cornall

Startup Scout 10 Nov 2022

ResQ Biotech is using bacteria to discover Alzheimer’s treatments

Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech is harnessing bacteria to test potential peptide treatments for these…

November 10, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

Companies in the cell and gene therapy space are struggling to raise investments amid adverse market conditions. However, this could be an opportunity for the strongest companies and investors to…

October 20, 2022 - 9 minutesmins - By Jonathan Smith

Caszyme crispr climate change Anastasiia Slynko

Interview 17 Oct 2022

CRISPR gene editing: a key tool for counteracting climate change

Monika Paulė, CEO and co-founder of the Lithuanian CRISPR developer Caszyme, explains how gene editing technology could fight climate change by boosting agriculture and biodiversity. The invention of CRISPR-Cas gene…

October 17, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 27 Sep 2022

EU Agriculture Ministers meet in Prague to discuss sustainability and food security

At an informal gathering of EU Agriculture Ministers, food security and the role of European agriculture and sustainable global food production were the main discussion points. At the meeting held…

September 27, 2022 - 5 minutesmins - By Liza Laws

News and Trends 27 Sep 2022

Capagro launches second fund of €200M to support promising European startups

The most promising startups in the European FoodTech and AgTech sectors will be supported by funding from Capagro. The European AgriTech is building on the success of its first fund…

September 27, 2022 - 4 minutesmins - By Liza Laws

In Depth 20 Sep 2022

Looming challenges for Europe’s cell and gene therapy space

The double whammy of Brexit and the COVID-19 pandemic have posed major logistical challenges for the development of cell and gene therapies (CGTs) in the last two years. In spite…

September 20, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 11 Aug 2022

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

Panbela Therapeutics, a U.S.-based clinical stage company, announced today (August 11) that it has enrolled its first patient in a global trial to evaluate a potential cure for pancreatic cancer.…

August 11, 2022 - 3 minutesmins - By Liza Laws

Interview 10 Aug 2022

How the UK precision breeding bill could unshackle gene editing

The U.K. is considering lowering restrictions on gene-edited crops. PacBio’s Neil Ward explains how the changes could impact the gene editing landscape. CRISPR gene editing technology has changed the game…

August 10, 2022 - 6 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering